Search alternatives:
structure optimization » structural optimization (Expand Search), structure determination (Expand Search)
based optimization » whale optimization (Expand Search)
binary factor » binary factors (Expand Search), primary factor (Expand Search)
free based » tree based (Expand Search), arene based (Expand Search)
structure optimization » structural optimization (Expand Search), structure determination (Expand Search)
based optimization » whale optimization (Expand Search)
binary factor » binary factors (Expand Search), primary factor (Expand Search)
free based » tree based (Expand Search), arene based (Expand Search)
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
Overview of study assessments of the trial.
Published 2024“…A QPOP-guided treatment selection algorithm will then be used to select the most appropriate drug combination. …”
-
16
-
17
-
18
Data Sheet 4_Identification of a signature gene set for oxaliplatin sensitivity prediction in colorectal cancer.pdf
Published 2025“…Background<p>Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide. Oxaliplatin-based chemotherapy is a cornerstone of treatment for many CRC patients; however, the development of chemoresistance severely limits its therapeutic efficacy and remains a major clinical challenge. …”
-
19
Data Sheet 1_Identification of a signature gene set for oxaliplatin sensitivity prediction in colorectal cancer.pdf
Published 2025“…Background<p>Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide. Oxaliplatin-based chemotherapy is a cornerstone of treatment for many CRC patients; however, the development of chemoresistance severely limits its therapeutic efficacy and remains a major clinical challenge. …”
-
20
Table 1_Identification of a signature gene set for oxaliplatin sensitivity prediction in colorectal cancer.xlsx
Published 2025“…Background<p>Colorectal cancer (CRC) is a leading cause of cancer-related mortality worldwide. Oxaliplatin-based chemotherapy is a cornerstone of treatment for many CRC patients; however, the development of chemoresistance severely limits its therapeutic efficacy and remains a major clinical challenge. …”